Radiation therapy raises $11 million: Sensus Healthcare prices upsized IPO below the range at $5.50

Sensus Healthcare, which sells low-energy x-ray systems for treating non-melanoma skin cancer and keloids, raised $11 million by offering 2 million units at $5.50.

Sensus originally planned to raise $20 million in March at a market cap of $97 million, but postponed the deal. It came back in May with a new underwriter and stapled warrants at a proposed price of $6.25 ($80 million market cap). Sensus Healthcare plans to list on the Nasdaq under the symbol SRTSU. Northland Securities and Neidiger, Tucker, Bruner acted as lead managers on the deal.

Share on Google Plus

About Jessica Hornberger

This is a short description in the author block about the author. You edit it by entering text in the "Biographical Info" field in the user admin panel.